Documentos relacionados

1. [Advances in immunotherapy of pancreatic ductal adenocarcinoma].
2. Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma.
3. Fibroblast diversity and plasticity in the tumor microenvironment: roles in immunity and relevant therapies.
4. Prognostic and immunotherapeutic significance of immunogenic cell death-related genes in colon adenocarcinoma patients.
5. Advances in cancer immunotherapies.
6. A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma.
7. Cell-Based Drug Delivery Systems Participate in the Cancer Immunity Cycle for Improved Cancer Immunotherapy.
8. Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect.
9. TIRSF: a web server for screening gene signatures to predict Tumor immunotherapy response.
10. Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer.